000 | 01124 a2200313 4500 | ||
---|---|---|---|
005 | 20250512012944.0 | ||
264 | 0 | _c19890922 | |
008 | 198909s 0 0 eng d | ||
022 | _a0361-7742 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKurth, K H | |
245 | 0 | 0 |
_aIntracavitary treatment of transitional cell carcinoma of the bladder: questions and lessons after 27 years of experience. _h[electronic resource] |
260 |
_bProgress in clinical and biological research _c1989 |
||
300 |
_a125-45 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAdministration, Intravesical |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aCarcinoma in Situ _xdrug therapy |
650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aNeoplasm Invasiveness |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdrug therapy |
700 | 1 | _aSylvester, R | |
700 | 1 | _ade Pauw, M | |
700 | 1 | _aten Kate, F | |
773 | 0 |
_tProgress in clinical and biological research _gvol. 310 _gp. 125-45 |
|
999 |
_c2677894 _d2677894 |